Your browser doesn't support javascript.
loading
Preserving Well-being in Patients With Advanced and Late Prostate Cancer.
Handley, Nathan R; Feng, Felix Y; Guise, Theresa A; D'Andrea, Denise; Kelly, William Kevin; Gomella, Leonard G.
Afiliación
  • Handley NR; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. Electronic address: nathan.handley@jefferson.edu.
  • Feng FY; Departments of Radiation Oncology, Urology, and Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.
  • Guise TA; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.
  • D'Andrea D; Janssen Scientific Affairs, LLC, Horsham, PA.
  • Kelly WK; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
  • Gomella LG; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Urology ; 155: 199-209, 2021 09.
Article en En | MEDLINE | ID: mdl-33373704
Androgen deprivation therapy, alone or in combination with androgen signaling inhibitors, is a treatment option for patients with advanced prostate cancer (PC). When making treatment decisions, health care providers must consider the long-term effects of treatment on the patient's overall health and well-being. Herein, we review the effects of these treatments on the musculoskeletal and cardiovascular systems, cognition, and fall risk, and provide management approaches for each. We also include an algorithm to help health care providers implement best clinical practices and interdisciplinary care for preserving the overall well-being of PC patients.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antagonistas de Andrógenos / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Urology Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antagonistas de Andrógenos / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Urology Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos